Nickan Research Institute Journal of Parathyroid Disease 2345-6558 6 2 2018 04 01 Magnesium and parathyroid hormone among end-stage renal disease patients 72 73 10.15171/jpd.2018.22 EN Seyed Seifollah Beladi Mousavi Fatemeh Hayati Shokouh Shayanpour Shahla Ahmadi Halili Journal Article 10.15171/jpd.2018.22 Implication for health policy/practice/research/medical educationHypermagnesemia is also not a prominent feature among patients with chronic kidney disease, in the absence of increased magnesium administration, however renal failure mostly at its final stages is most common cause of hypermagnesemia.